- Patent Title: Methods of use of soluble CD24 for therapy of rheumatoid arthritis
-
Application No.: US16104072Application Date: 2018-08-16
-
Publication No.: US10793617B2Publication Date: 2020-10-06
- Inventor: Xincheng Zheng , Wei Wu , Yang Liu , Pan Zheng
- Applicant: OncoImmune, Inc.
- Applicant Address: US MD Rockville
- Assignee: ONCOIMMUNE, INC.
- Current Assignee: ONCOIMMUNE, INC.
- Current Assignee Address: US MD Rockville
- Agency: Polsinelli PC
- Agent Ron Galant
- Main IPC: C07K16/46
- IPC: C07K16/46 ; C07K14/47 ; C07K14/00 ; A61K45/06 ; A61K38/00 ; C07K14/705 ; C07K14/435 ; C07K19/00
Abstract:
Provided herein is a CD24 protein. The CD24 protein may include mature human or mouse CD24, as well as a N- or C-terminally fused portion of a mammalian immunoglobulin.
Public/Granted literature
- US20190016783A1 METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS Public/Granted day:2019-01-17
Information query
